Matthew Fuchter and his OBC article on Psammaplin A around the world

Matthew Fuchter‘s research on Psammaplin A has proven to be very well received by the public all over the world.
Dr Fuchter and his team at Imperial College in London, published a new way of making psammaplin A which has the potential to inspire novel anti-cancer drugs (OBC Issue 3).

You can see below some of the links highlighting this story.

From the Editorial Office, we would like to congratulate Matthew and his group for a very successful paper and a very promising research.

The article is now free to access for 4 weeks. Don’t miss out and read it now.

New synthetic strategies towards psammaplin A, access to natural product analogues for biological evaluation
Matthias G. J. Baud, Thomas Leiser, Franz-Josef Meyer-Almes and Matthew J. Fuchter
Org. Biomol. Chem., 2011, 9, 659-662
DOI: 10.1039/C0OB00824A, Communication

Digg This
Reddit This
Stumble Now!
Share on Facebook
Bookmark this on Delicious
Share on LinkedIn
Bookmark this on Technorati
Post on Twitter
Google Buzz (aka. Google Reader)